The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of NBS1 expression with improved pathologic complete response rate in HER2-overexpressing breast cancer.
Fatma Sen
No relevant relationships to disclose
Ekrem Yavuz
No relevant relationships to disclose
Gulcin Yegen
No relevant relationships to disclose
Hasan Karanlik
No relevant relationships to disclose
Sitki Tuzlali
No relevant relationships to disclose
Adnan Aydiner
No relevant relationships to disclose